cpcvisual_edited.jpg

Active oral protection

for optimum health.

VITIS® CPC protect mouthwash & toothpaste

VITIS® CPC protect mouthwash & toothpaste are specially formulated for those seeking active oral protection for optimum health.

What is CPC ?

 

 

 

 

 

Cetylpyridinium Chloride (CPC) is a safe and effective daily-use antiseptic with antiplaque action and a substantivity of between 3 and 5 hours.

 

Protect your mouth

now more than ever !

Formulated with CPC to ensure active oral protection

  • People seeking active oral protection for optimum health.

  • Those seeking extra daily care protection.

  • Suitable for people suffering from coeliac disease.

How to use

  • People who are looking for active oral protection for an optimal health

  • People who are looking for extra protection in their daily care

  • Suitable for coeliacs

COMPOSITION

  • VITIS® CPC protect mouthwash is formulated with a 0.07% concentration of Cetylpyridinium chloride (CPC).

  • VITIS® CPC protect toothpaste: 0.14% CPC
    1450 ppm Sodium fluoride

ACTION

  • Protects and strengthens gums

  • Increase substantivity of CPC

  • Reinforces enamel

  • Reduces plaque (biofilm) build-up. Reduces virus particles; see Clinical trials related to Covid-19-Sars2. 

  • Daily-use anti-plaque that prevents the formation of
    dental plaque (biofilm) and helps reduce the accumulation thereof.18,19,20
    • Remineralises enamel and prevents dental caries.

75ml                           500ml
Reinforce your oral hygiene on a daily basis

Cetylpyridinium Chloride (CPC) 

Cetylpyridinium Chloride (CPC)
Scientific evidence

Cetylpyridinium Chloride (CPC) 

1. Xu H, Zhong L, Deng J, Peng J, Dan H, Zeng X, et al.High expression of ACE2
receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int J Oral Sci. 2020
Feb 24;12(1):8.
2. Rabi FA, Al Zoubi MS, Kasasbeh GA, Salameh DM, Al-Nasser AD. SARS-CoV-2 and
Coronavirus Disease 2019: What We Know So Far. Pathogens. 2020 Mar 20;9(3)
3. Wölfel R. Corman VM, Guggemos W, Seilmaier M, Zange S, Müller MA, et al.
Virological assessment of hospitalized patients with COVID-2019. Nature https://-
doi.org/10.1038/s41586-020-2196-x (2020).
4. Peng X, Xu X, Li Y, Cheng L, Zhou X, Ren B. Transmission routes of 2019-nCoV
and controls in dental practice. Int J Oral Sci. 2020 Mar 3;12(1):9
5. Liu Y, Yan LM, Wan L, Xiang TX, Le A, Liu JM, Peiris M, Poon LLM, Zhang W. Viral
dynamics in mild and severe cases of COVID-19. Lancet Infect Dis. 2020 Mar 19.
pii: S1473-3099(20)30232-

6. Popkin DL,ZilkaS,DimaanoM, Fujioka H, Rackley C,SalataR et al.Cetylpyridinium
chloride (CPC) exhibits potent, rapid activitygainstinfluenza viruses in
vitro and in vivo.PathogensandImmunity. 2017;2(2):253-69.
7. Mukherjee PK, Esper F, Buchheit K, Arters K, Adkins I, Ghannoum MAet al.
Randomized, double-blind, placebo-controlled clinical trial to assess the safety
and effectiveness of a novel dual-action oral topical formulation against upper
respiratory infections. BMC Infect Dis. 2017 Jan 14;17(1):74
8. Liang Shen, Junwei Niu, Chunhua Wang, Baoying Huang, Wenling Wang, Na
Zhu, Yao Deng, Huijuan Wang, Fei Ye, Shan Cen, Wenjie Tan. 2019. High-Throughput
Screening and Identification of Potent Broad-Spectrum Inhibitors of Coronaviruses.
Journal of Virology. doi: 10.1128/JVI.00023-19 93 (12)
9. Quirynen M, Avontroodt P, Soers C, Zhao H, Pauwels M, van Steenberghe D.
Impact of tongue cleansers on microbial load and taste. J Clin Periodontol 2004;
31: 506–510.

corona.png
corona2.png